Cargando…
Author Correction: A phase I clinical trial for [(131)I]meta-iodobenzylguanidine therapy in patients with refractory pheochromocytoma and paraganglioma
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8770502/ https://www.ncbi.nlm.nih.gov/pubmed/35046473 http://dx.doi.org/10.1038/s41598-022-05239-2 |
| _version_ | 1784635387635826688 |
|---|---|
| author | Wakabayashi, Hiroshi Inaki, Anri Yoshimura, Kenichi Murayama, Toshinori Imai, Yasuhito Higuchi, Tetsuya Jinguji, Megumi Shiga, Tohru Kinuya, Seigo |
| author_facet | Wakabayashi, Hiroshi Inaki, Anri Yoshimura, Kenichi Murayama, Toshinori Imai, Yasuhito Higuchi, Tetsuya Jinguji, Megumi Shiga, Tohru Kinuya, Seigo |
| author_sort | Wakabayashi, Hiroshi |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8770502 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-87705022022-01-20 Author Correction: A phase I clinical trial for [(131)I]meta-iodobenzylguanidine therapy in patients with refractory pheochromocytoma and paraganglioma Wakabayashi, Hiroshi Inaki, Anri Yoshimura, Kenichi Murayama, Toshinori Imai, Yasuhito Higuchi, Tetsuya Jinguji, Megumi Shiga, Tohru Kinuya, Seigo Sci Rep Author Correction Nature Publishing Group UK 2022-01-19 /pmc/articles/PMC8770502/ /pubmed/35046473 http://dx.doi.org/10.1038/s41598-022-05239-2 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Author Correction Wakabayashi, Hiroshi Inaki, Anri Yoshimura, Kenichi Murayama, Toshinori Imai, Yasuhito Higuchi, Tetsuya Jinguji, Megumi Shiga, Tohru Kinuya, Seigo Author Correction: A phase I clinical trial for [(131)I]meta-iodobenzylguanidine therapy in patients with refractory pheochromocytoma and paraganglioma |
| title | Author Correction: A phase I clinical trial for [(131)I]meta-iodobenzylguanidine therapy in patients with refractory pheochromocytoma and paraganglioma |
| title_full | Author Correction: A phase I clinical trial for [(131)I]meta-iodobenzylguanidine therapy in patients with refractory pheochromocytoma and paraganglioma |
| title_fullStr | Author Correction: A phase I clinical trial for [(131)I]meta-iodobenzylguanidine therapy in patients with refractory pheochromocytoma and paraganglioma |
| title_full_unstemmed | Author Correction: A phase I clinical trial for [(131)I]meta-iodobenzylguanidine therapy in patients with refractory pheochromocytoma and paraganglioma |
| title_short | Author Correction: A phase I clinical trial for [(131)I]meta-iodobenzylguanidine therapy in patients with refractory pheochromocytoma and paraganglioma |
| title_sort | author correction: a phase i clinical trial for [(131)i]meta-iodobenzylguanidine therapy in patients with refractory pheochromocytoma and paraganglioma |
| topic | Author Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8770502/ https://www.ncbi.nlm.nih.gov/pubmed/35046473 http://dx.doi.org/10.1038/s41598-022-05239-2 |
| work_keys_str_mv | AT wakabayashihiroshi authorcorrectionaphaseiclinicaltrialfor131imetaiodobenzylguanidinetherapyinpatientswithrefractorypheochromocytomaandparaganglioma AT inakianri authorcorrectionaphaseiclinicaltrialfor131imetaiodobenzylguanidinetherapyinpatientswithrefractorypheochromocytomaandparaganglioma AT yoshimurakenichi authorcorrectionaphaseiclinicaltrialfor131imetaiodobenzylguanidinetherapyinpatientswithrefractorypheochromocytomaandparaganglioma AT murayamatoshinori authorcorrectionaphaseiclinicaltrialfor131imetaiodobenzylguanidinetherapyinpatientswithrefractorypheochromocytomaandparaganglioma AT imaiyasuhito authorcorrectionaphaseiclinicaltrialfor131imetaiodobenzylguanidinetherapyinpatientswithrefractorypheochromocytomaandparaganglioma AT higuchitetsuya authorcorrectionaphaseiclinicaltrialfor131imetaiodobenzylguanidinetherapyinpatientswithrefractorypheochromocytomaandparaganglioma AT jingujimegumi authorcorrectionaphaseiclinicaltrialfor131imetaiodobenzylguanidinetherapyinpatientswithrefractorypheochromocytomaandparaganglioma AT shigatohru authorcorrectionaphaseiclinicaltrialfor131imetaiodobenzylguanidinetherapyinpatientswithrefractorypheochromocytomaandparaganglioma AT kinuyaseigo authorcorrectionaphaseiclinicaltrialfor131imetaiodobenzylguanidinetherapyinpatientswithrefractorypheochromocytomaandparaganglioma |